Delcath Systems Inc Share Price Today: Live Updates & Key Insights

Delcath Systems Inc share price today is $9.2, up -2.89%. The stock opened at $9.2 against the previous close of $9.34, with an intraday high of $9.27 and low of $8.97.

Delcath Systems Inc Share Price Chart

Delcath Systems Inc

us-stock
To Invest in {{usstockname}}
us-stock

Delcath Systems Inc Share Price Performance

$9.2 -0.0289(-2.89%) DCTH at 23 Mar 2026 12:39 PM Medical Devices
Lowest Today 8.97
Highest Today 9.27
Today’s Open 9.2
Prev. Close 9.34
52 Week High 18.23
52 Week Low 8.12
Day’s Range: Low 8.97 High 9.27
52-Week Range: Low 8.12 High 18.23
1 day return -
1 Week return -7.64
1 month return -7.07
3 month return -9.94
6 month return -21.89
1 year return -35.05
3 year return +98.46
5 year return -50.76
10 year return -

Delcath Systems Inc Institutional Holdings

Rosalind Advisors, Inc. 9.50

BlackRock Inc 5.09

Vanguard Group Inc 4.81

Vanguard Total Stock Mkt Idx Inv 2.83

iShares Russell 2000 ETF 2.08

Geode Capital Management, LLC 1.97

State Street Corp 1.79

Divisadero Street Capital Management, LP 1.37

Propel Bio Management LLC 1.26

Ikarian Capital, LLC 1.24

ExodusPoint Capital Management, LP 1.09

Citadel Advisors Llc 1.06

Renaissance Technologies Corp 1.04

Fidelity Small Cap Index 0.84

Private Wealth Advisors, LLC 0.84

Vanguard Institutional Extnd Mkt Idx Tr 0.81

The Goldman Sachs Group Inc 0.78

Palisades Investment Partners, LLC 0.77

Simplify Asset Management Inc. 0.75

Simplify Propel Opportunities ETF 0.75

Morgan Stanley - Brokerage Accounts 0.73

Northern Trust Corp 0.73

Millennium Management LLC 0.71

iShares Russell 2000 Growth ETF 0.70

ADAR1 Capital Management LLC 0.65

Jane Street Group LLC 0.61

State St Russell Sm/Mid Cp® Indx SL Cl I 0.54

Fidelity Extended Market Index 0.41

Vanguard Russell 2000 ETF 0.41

Palisades Small Cap Core 0.32

Kennedy Micro Cap 0.31

State St Russell Sm Cap® Indx SL Cl I 0.30

Kennedy Micro Cap Opportunities 0.27

Royce Micro-Cap Trust 0.27

North Square Dynamic Small Cap I 0.26

iShares Micro-Cap ETF 0.23

Schwab Small Cap Index 0.22

NT R2000 Index Fund - NL 0.19

Blackrock Extended Mkt Fund CF 0.18

Stt Strt SPDR® Russell2000 US SmCapETF 0.16

Delcath Systems Inc Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Delcath Systems Inc Fundamentals

Market Cap 320.30 M

PB Ratio 2.8336

PE Ratio 129.5714

Enterprise Value 225.05 M

Total Assets 123.63 M

Volume 517895

Delcath Systems Inc Company Financials

Annual Revenue FY23:2165000 2.2M, FY22:2719000 2.7M, FY21:3555000 3.6M, FY20:1646000 1.6M, FY19:1580000 1.6M

Annual Profit FY23:1464000 1.5M, FY22:2033000 2.0M, FY21:2884000 2.9M, FY20:1006000 1.0M, FY19:861000 0.9M

Annual Net worth FY23:-45014000 -45.0M, FY22:-39163000 -39.2M, FY21:-26757000 -26.8M, FY20:-24485000 -24.5M, FY19:-13627000 -13.6M

Quarterly Revenue Q3/2025:20563000 20.6M, Q2/2025:24156000 24.2M, Q1/2025:19784000 19.8M, Q3/2024:9560000 9.6M, Q2/2024:7766000 7.8M

Quarterly Profit Q3/2025:17939000 17.9M, Q2/2025:20838000 20.8M, Q1/2025:16939000 16.9M, Q3/2024:9560000 9.6M, Q2/2024:6247000 6.2M

Quarterly Net worth Q3/2025:830000 0.8M, Q2/2025:2697000 2.7M, Q1/2025:1069000 1.1M, Q3/2024:1864000 1.9M, Q2/2024:-13741000 -13.7M

About Delcath Systems Inc & investment objective

Company Information Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.

Organisation Medical Devices

Employees 156

Industry Medical Devices

CEO Mr. Gerard J. Michel MBA, MS

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Delcath Systems Inc FAQs

What is the share price of Delcath Systems Inc today?

The current share price of Delcath Systems Inc is $9.2.

Can I buy Delcath Systems Inc shares in India?

Yes, Indian investors can buy Delcath Systems Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Delcath Systems Inc shares in India?

You can easily invest in Delcath Systems Inc shares from India by:

Can I buy fractional shares of Delcath Systems Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Delcath Systems Inc?

Delcath Systems Inc has a market cap of $320.30 M.

In which sector does Delcath Systems Inc belong?

Delcath Systems Inc operates in the Medical Devices sector.

What documents are required to invest in Delcath Systems Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Delcath Systems Inc?

The PE ratio of Delcath Systems Inc is 129.57 and the PB ratio is 2.83.